HRT FINANCIAL LP - 10 Jun 2026 Form 4 Insider Report for Clearmind Medicine Inc. (CMND)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Jun 2026, 16:42:57 UTC
Prior SEC filing
11 Jun 2026
Next SEC filing
16 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Adam Nunes

Key filing fact

HRT FINANCIAL LP filed Form 4 for Clearmind Medicine Inc. (CMND) on 17 Jun 2026.

Key facts

  • This page summarizes HRT FINANCIAL LP's Form 4 filing for Clearmind Medicine Inc. (CMND).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jun 2026, 16:42.

Change

  • Previous filing in this sequence was filed on 11 Jun 2026.
  • Current net transaction value: -$10,568.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001475597 Primary reporting owner

HRT FINANCIAL LP

Relationship
10%+ Owner
Address
3 WORLD TRADE CENTER, 175 GREENWICH STRE, 76TH FLOOR, NEW YORK
Signature
Adam Nunes
Signature date
17 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CMND transaction

Common Stock

Sale

Transaction value
$10,568
Shares
-3,183
Change %
-3%
Price
$3.32
Shares after
103,492
Date
15 Jun 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .